Can I Stop Taking Wegovy for a Week — and What Happens If You Do?

The myth: a week off is just a pause with no real consequence

A common assumption is that missing one Wegovy injection is roughly equivalent to skipping a vitamin, inconvenient but quickly corrected. That picture is not accurate. Semaglutide's half-life is approximately seven days, which means that after a single missed weekly dose, the effective concentration in your system has already halved. The appetite suppression and slowed gastric emptying that make the medicine work are tied directly to that concentration. By day four or five without a dose, many people notice hunger returning with more urgency than they have felt in some time. This is not a failure of willpower; it is pharmacology.

The misconception matters because people planning a holiday, a surgery or a week without fridge access sometimes tell themselves the gap will not register. In practice, the week itself can be manageable if eating habits stay broadly consistent, but the risk is what fills the gap. When appetite returns sharply and familiar foods are more available than usual (think: a holiday buffet), the conditions for rapid energy intake are easy to underestimate. The Wegovy treatment overview on our site explains how the medicine works across the full dosing schedule, which gives useful context here.

The factual starting point is this: one missed dose is a pause; two or three consecutive missed doses starts to look more like a temporary discontinuation. Those two situations carry different clinical implications.

What the evidence says about stopping semaglutide, even briefly

The clearest evidence on stopping semaglutide comes from withdrawal data in the STEP trials. In STEP 1, published in the New England Journal of Medicine, participants who stopped semaglutide 2.4mg after 68 weeks regained roughly two-thirds of the weight they had lost within a year. That was a full discontinuation, not a week's break, but the underlying mechanism is the same. The body's weight-regulatory biology had not changed; the medicine was doing the work, and removing it allowed the original drivers of weight gain to reassert themselves.

A single week is a much smaller interruption, and for most people at a stable maintenance dose the effect on overall progress is limited if the break is genuinely brief and they restart promptly. If you want a sense of the kind of results people achieve before any gap risks reversing them, browsing our Wegovy before and afters can help put the stakes of unplanned breaks into perspective. The more important question is whether the plan to stop for one week becomes two weeks, then a month. That is the pattern that leads to meaningful weight regain, and it is the reason prescribers tend to discuss any planned gap rather than treat it as unremarkable. You can read more about the broader picture of stopping Wegovy and what to expect if a longer break becomes necessary.

A quick practical check worth doing before any planned week off: look at when your next pen arrives relative to your injection schedule. If you are already due to start a new pen and you delay, you may inadvertently create a two-week gap rather than one. Confirming the date on the pen in your fridge takes under a minute and can prevent an accidental double-miss.

Restarting after a week away, what your prescriber will want to know

Most people who miss a single dose and restart the following week do so at their current dose without stepping down, provided the missed dose was genuinely isolated. The Patient Information Leaflet for Wegovy states that if you miss a dose and your next scheduled injection is more than five days away, you should take the missed dose as soon as possible. If the next dose is due within five days, skip the missed one and continue from your usual day. Always confirm this with the specific leaflet for your pen or with your prescriber, dosing guidance is their call, not something to follow from general articles.

Where things become more complicated is a break of several weeks. After a gap of that length, some prescribers will recommend stepping back to a lower dose before returning to maintenance. This is because the tolerability benefits that come with gradual titration reset somewhat during a prolonged break, and jumping straight back to a higher dose can bring a significant return of nausea, vomiting or other gastrointestinal effects. The process of stopping Wegovy and how to approach restarting is covered in detail in a dedicated guide.

If your gap was prompted by a side effect rather than convenience, that is a separate and more important clinical conversation. Stopping because of persistent nausea, injection-site reactions or any symptom that concerned you is a reason to speak to a prescriber before restarting, not after. The contact page details how to reach the team at any point.

The cost dimension, and why gaps sometimes happen for financial reasons

It would be unrealistic not to acknowledge that some people stop for a week because of cost. Wegovy is a significant monthly expense as a private prescription, and if a pen's timing falls awkwardly around a payday or an unexpected bill, skipping a week can feel like the obvious short-term solution. This is not unusual, and it is better to be transparent about it with your prescriber than to quietly miss doses.

There is also a structural point worth noting. If you are considering whether the overall cost is sustainable, understanding exactly what is included in a private prescription is worth doing before any gap becomes a habit. The Wegovy cost guide breaks down what a full private prescription typically covers, consultation, clinical review, supply and aftercare. At nume, there are no subscriptions and no automatic renewals; every order is re-reviewed clinically, which also means a prescriber sees your situation before each dispatch. That model is not cheaper by design, but it does mean nobody is dispensing to you on autopilot.

If you are unsure whether treatment is still the right fit (financially, clinically or practically) that uncertainty is exactly what a prescriber conversation is for. Knowing when stopping is clinically appropriate is a separate question from whether a week off is harmless, and both deserve a proper answer.